Engage | Sign In | Join Now
Tara Rachinsky
Tara

Last updated: 1/7/2025
Tara Rachinsky
Professional + Freelance Package
Profile Link: http://www.amwa.org/member/tara-rachinsky
Philadelphia
Pennsylvania
United States
 215-703-8633 (Phone)
Visit Website »
Philadelphia
Pennsylvania
United States
 215-703-8633 (Phone)
Freelance Directory Listing
  Valence Biomedical Communications LLC
  Philadelphia
  PA
  United States
  215-703-8633
  tara@valencebiomed.com
  http://valencebiomed.com
  PhD in Physiology and Pharmacology
  At Valence Biomedical Communications, I translate complex scientific information into clear, compelling content that is focused on your results, tailored to your audience, and delivered on your schedule.

CONTENT
• Research manuscripts (preclinical studies, clinical trials)
• Review articles
• Abstracts
• Posters
• Continuing medical education (CME) materials
• Needs assessments
• Slide presentations
• Meeting reports and summaries
• Medical news
• White papers

SERVING
• Biotechnology and pharmaceutical companies
• Medical communications agencies
• Medical education companies
• Non-profit organizations

SCIENTIFIC AND THERAPEUTIC AREAS
• Biologics: biosimilars, interferon-beta (IFN-ß), factor VIII, antibodies (monoclonal antibodies, single-domain antibodies, nanobodies, humanized antibodies, chimeric antibodies, antibody-drug conjugates [ADCs], cysteine-engineered antibodies)
• Biotechnology
• Cell and molecular biology
• Central nervous system (CNS) and neurology: Alzheimer's disease, BACE inhibitors, epilepsy, Friedreich’s ataxia, migraine, major depressive disorder, myasthenia gravis, neurotoxicity, neurodegeneration, neuromyelitis optica spectrum disorder (NMOSD), pain, Parkinson’s disease, tau-modulating drugs
• Dermatology: atopic dermatitis, psoriasis, rosacea
• Diagnostics: biomarkers, microfluidic chips, multiplex PCR, prenatal diagnostics, molecular diagnostics
• Drug delivery: transdermal delivery, ultrasound-mediated delivery, aerosol formulations, immediate release, modified release, controlled release, delayed release, sustained release, extended release, pulsatile release, osmotic release systems, matrix systems, PEGylation, encapsulation, nanotechnology
• Gastroenterology: inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis
• Gene therapy: adenovirus, adeno-associated virus (AAV), clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR-Cas9), gene editing, ultrasound-assisted gene transfer, exon-skipping, oligonucleotide therapeutics
• Genomics: copy number variation (CNV), single nucleotide polymorphism (SNP), single nucleotide variant (SNV), genome-wide association studies (GWAS), mutations, pharmacogenomics, proteomics, personalized medicine, precision medicine
• Hematology: alpha-thalassemia, coagulation, hemophilia, multiple myeloma, plasminogen deficiency type 1 (PLGD-1), sickle cell disease, thrombosis
• Immunology and inflammation: systemic lupus erythematosus (SLE), multiple sclerosis, rheumatoid arthritis (RA), plaque psoriasis, complement activation products
• Medical devices
• Medical informatics: big data, biomedical database, image analysis, predictive analytics
• Nucleic acid drugs: aptamers, RNA interference (RNAi), small interfering RNA (siRNA), short hairpin RNA (shRNA), microRNA (miRNA), antisense oligonucleotides (ASOs)
• Nutrition: nutraceuticals, obesity, probiotics
• Oncology: basal cell carcinoma, breast cancer, colorectal cancer, gastrointestinal stromal tumor (GIST), melanoma, multiple myeloma, non-small cell lung cancer (NSCLC), renal cell carcinoma, cancer clinical trial design, checkpoint inhibitors (eg, inhibitors of PD-1, PD-L1, CTLA-4), immunotherapy, intratumoral delivery, oncolytic viruses, targeted therapy
• Ophthalmology: age-related macular degeneration (AMD), cataract surgery, diabetic macular edema (DME), diabetic retinopathy, glaucoma, inherited retinal diseases (IRDs), ligneous conjunctivitis, neovascular AMD (nAMD), refractive surgery, Stargardt disease, X-linked retinitis pigmentosa (XLRP)
• Otolaryngology: otitis media, hearing loss
• Pharmaceuticals: analgesics, antibiotics, anticoagulants, antihistamines, antineoplastic agents, protein kinase inhibitors, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, antipsychotics, immunosuppressants, leukotriene receptor antagonists, androgens, statins, gonadotropin-releasing hormone receptor antagonists
• Radiology: magnetic resonance imaging (MRI), functional MRI (fMRI), filter-exchange imaging (FEXI)
• Rare diseases: alpha-thalassemia, Duchenne muscular dystrophy (DMD), Friedreich’s ataxia, myasthenia gravis, myotonic dystrophy, neuromyelitis optica spectrum disorder (NMOSD), plasminogen deficiency type 1 (PLGD-1), retinitis pigmentosa, Stargardt disease
• Signal transduction: apoptosis, hedgehog inhibitors, Janus kinases (JAKs), tyrosine kinase inhibitors (TKIs), sequestosome-1 (p62), B-cell lymphoma 2 (Bcl-2), death-associated protein kinase 1 (DAPK1), cytokines, interferons, interleukins, tumor necrosis factors (TNFs), mitogen-activated protein kinases (MAPKs), p38, c-Jun N-terminal kinases (JNKs), bone morphogenetic proteins (BMPs)
• Telemedicine, telehealth
• Women's health: dysmenorrhea, endometriosis, menopause
  Education (professional audience), Meeting Services, Publications/Publishing, Writing (general)
  http://www.linkedin.com/in/tara-rachinsky-freelance-medical-writer
  No
Contact Us

American Medical Writers Association
9841 Washingtonian Blvd, Suite 500-26
Gaithersburg, MD 20878

phone:  240. 238. 0940
fax:        301. 294. 9006
amwa@amwa.org

About Us
Contact AMWA Staff
© 2025 AMWA / Policies